Entrada Therapeutics Inc's Comment on Supply Chain
The company sources suppliers for EEV peptides, including linkers and nucleotides, used in therapeutic candidates such as ENTR-601-44, ENTR-601-45, ENTR-601-50, ENTR-601-51, ENTR-801, and VX-670. These suppliers support investigational new drug (IND)-enabling studies, clinical trials, and commercial activities. The company may establish its own manufacturing facility in the future and plans to expand its network of Contract Manufacturing Organizations (CMOs) as manufacturing scales. Multiple sources exist for all materials required for manufacturing these therapeutic candidates, and several CMOs are capable of assembling the components. Manufacturing activities are subject to extensive regulation, including compliance with current Good Manufacturing Practice (CGMP) and other applicable laws. The company employs personnel with technical, manufacturing, analytical, and quality expertise to oversee contracted manufacturing and testing operations.
Entrada Therapeutics Inc's Comment on Supply Chain
The company sources suppliers for EEV peptides, including linkers and nucleotides, used in therapeutic candidates such as ENTR-601-44, ENTR-601-45, ENTR-601-50, ENTR-601-51, ENTR-801, and VX-670. These suppliers support investigational new drug (IND)-enabling studies, clinical trials, and commercial activities. The company may establish its own manufacturing facility in the future and plans to expand its network of Contract Manufacturing Organizations (CMOs) as manufacturing scales. Multiple sources exist for all materials required for manufacturing these therapeutic candidates, and several CMOs are capable of assembling the components. Manufacturing activities are subject to extensive regulation, including compliance with current Good Manufacturing Practice (CGMP) and other applicable laws. The company employs personnel with technical, manufacturing, analytical, and quality expertise to oversee contracted manufacturing and testing operations.
Sources:
Entrada Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Entrada Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
